Literature DB >> 11969429

Phosphatidylserine binding alters the conformation and specifically enhances the cofactor activity of bovine factor Va.

Xin Zhai1, Arvind Srivastava, Daryl C Drummond, David Daleke, Barry R Lentz.   

Abstract

Factor V(a) is a cofactor for the serine protease factor X(a) that activates prothrombin to thrombin in the presence of Ca(2+) and a platelet membrane surface. A platelet membrane lipid, phosphatidylserine (PS), regulates the proteolytic activity of factor X(a) as well as the structure of prothrombin. Here we ask whether PS also regulates the structure and cofactor activity of factor V(a), which is a heterodimer composed of one heavy chain (A1-A2 domains) and one light chain (A3-C1-C2 domains). We use fluorescence, circular dichroism, equilibrium dialysis, and activity measurements to demonstrate the following: (1) Factor V(a) has four sites for dicaproyl-sn-glycero-3-phospho-L-serine (C(6)PS, a soluble form of PS); the heavy and light chains each bind two C(6)PS molecules. (2) In the absence of Ca(2+), only two sites remain, one in the heavy chain and another in the light chain. (3) Binding to these sites causes conformational changes evidenced by changes in intrinsic fluorescence and in CD spectra and changes in cofactor activity. (4) At least some of the four lipid binding sites are nonspecific with respect to soluble lipid species, but the site(s) that regulate(s) cofactor activity is (are) specific for C(6)PS, phosphatidic acid, or phosphatidyl(homo)serine and produce a response comparable to that seen with a PS-containing membrane. (5) Like Ca(2+), C(6)PS also mediates the interaction between factor V(a) heavy (V(a)-HC) and light (V(a)-LC) chains. We conclude that PS regulates both the cofactor and the enzyme of the prothrombin-activating complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11969429     DOI: 10.1021/bi011844d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Interaction of dicaproyl phosphatidylserine with recombinant factor VIII and its impact on immunogenicity.

Authors:  Vivek S Purohit; Sathyamangalam V Balasubramanian
Journal:  AAPS J       Date:  2006-05-26       Impact factor: 4.009

2.  Functional and structural characterization of factor Xa dimer in solution.

Authors:  Rima Chattopadhyay; Roxana Iacob; Shalmali Sen; Rinku Majumder; Kenneth B Tomer; Barry R Lentz
Journal:  Biophys J       Date:  2009-02       Impact factor: 4.033

3.  Association free energy of dipalmitoylphosphatidylserines in a mixed dipalmitoylphosphatidylcholine membrane.

Authors:  Yoel Rodríguez; Mihaly Mezei; Roman Osman
Journal:  Biophys J       Date:  2007-02-02       Impact factor: 4.033

4.  Lower inhibitor development in hemophilia A mice following administration of recombinant factor VIII-O-phospho-L-serine complex.

Authors:  Vivek S Purohit; Karthik Ramani; Rita Sarkar; Haig H Kazazian; Sathyamangalam V Balasubramanian
Journal:  J Biol Chem       Date:  2005-02-23       Impact factor: 5.157

5.  Modulation of prothrombinase assembly and activity by phosphatidylethanolamine.

Authors:  Rinku Majumder; Xiaoe Liang; Mary Ann Quinn-Allen; William H Kane; Barry R Lentz
Journal:  J Biol Chem       Date:  2011-08-22       Impact factor: 5.157

6.  A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex.

Authors:  Rinku Majumder; Mary Ann Quinn-Allen; William H Kane; Barry R Lentz
Journal:  Blood       Date:  2008-06-27       Impact factor: 22.113

7.  Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution.

Authors:  Rinku Majumder; Tilen Koklic; Alireza R Rezaie; Barry R Lentz
Journal:  Biochemistry       Date:  2012-12-27       Impact factor: 3.162

8.  Effects of water soluble phosphotidylserine on bovine factor Xa: functional and structural changes plus dimerization.

Authors:  Rinku Majumder; Jianfang Wang; Barry R Lentz
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

9.  O-phospho-L-serine, multi-functional excipient for B domain deleted recombinant factor VIII.

Authors:  Razvan D Miclea; Vivek S Purohit; Sathy V Balu-Iyer
Journal:  AAPS J       Date:  2007-06-29       Impact factor: 4.009

10.  Protein structure and oligomerization are important for the formation of export-competent HIV-1 Rev-RRE complexes.

Authors:  Stephen P Edgcomb; Angelique Aschrafi; Elizabeth Kompfner; James R Williamson; Larry Gerace; Mirko Hennig
Journal:  Protein Sci       Date:  2008-01-24       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.